Alethea Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,813
Closed -$676K 99
2021
Q3
$676K Buy
+1,813
New +$689K 0.6% 24

Other funds holding ELV

Alethea Capital Management's ELV Position: Q4 2021 in Review

Alethea Capital Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 1,813 shares — an estimated $676K sold.

Alethea Capital Management first reported a position in ELV in Q3 2021 and held it in 1 quarter. The position peaked at $676K in Q3 2021. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Alethea Capital Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Alethea Capital Management sold 1,813 Elevance Health shares in Q4 2021, an estimated $676K.
  • Alethea Capital Management first reported a position in Elevance Health in Q3 2021 and held it in 1 quarter.
  • Alethea Capital Management's Elevance Health position peaked at $676K in Q3 2021.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Alethea Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.